Abstract
The aim of this study was to estimate the diagnostic sensitivity of thyroid autoantibodies in individuals with a case-mix of subjects with thyroid disease representing that of the general population. We measured thyroid microsome (TMA), thyroid peroxidase (TPO), thyroglobulin (TGA) and thyroid-stimulating hormone (TSH) receptor (TRA) autoantibodies in subjects in the bottom (hyperthyroid end) and top (hypothyroid end) four percentiles of the TSH distribution from among participants in a population-based survey of individuals aged ≥40 years (the Cremona Study). TMA and TPO were the most sensitive autoantibodies in subjects in both the bottom percentiles (19.8% and 18.5%, respectively) and the top percentiles (51.2% and 53.8%, respectively) of the TSH distribution. TMA and TPO showed good agreement (kappa statistics 87.8%, 95% CI 80.1–95.5%) at both ends of the TSH distribution. TGA were the next most sensitive marker, although seldom detected if TMA or TPO were not present. TRA were detected only at the extremes of the TSH distribution (1st percentile, 31.8%; 100th percentile, 25.0%). We conclude that, among a case-mix of individuals with thyroid disease representing that of the general population, TMA and TPO are the most sensitive markers of thyroid disease. TGA only marginally increased the diagnostic sensitivity of TMA and TPO. TRA are sensitive markers of thyroid disease only at the extremes of thyroid function.
Keywords: Thyroid disease, Population-based studies, Thyroid autoantibodies, Autoimmune thyroid disease, Autoantibody screening
References
- 1.Czarnocka B., Ruf J., Ferrand M., et al. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett. 1985;190:147–152. doi: 10.1016/0014-5793(85)80446-4. [DOI] [PubMed] [Google Scholar]
- 2.Portmann L., Hamada N., Heinrich G., DeGroot L.J. Antithyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti-microsomal antibody. J Clin Endocrinol Metab. 1985;61:1001–1003. doi: 10.1210/jcem-61-5-1001. [DOI] [PubMed] [Google Scholar]
- 3.Sinclair D. Clinical and laboratory aspects of thyroid autoantibodies. Ann Clin Biochem. 2006;43:173–183. doi: 10.1258/000456306776865043. [DOI] [PubMed] [Google Scholar]
- 4.Lind P., Langsteger W., Molnar M., et al. Epidemiology of thyroid diseases in iodine sufficiency. Thyroid. 1998;8:1179–1183. doi: 10.1089/thy.1998.8.1179. [DOI] [PubMed] [Google Scholar]
- 5.Laurberg P., Pedersen K.M., Hreidarsson A., et al. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab. 1998;83:765–769. doi: 10.1210/jcem.83.3.4624. [DOI] [PubMed] [Google Scholar]
- 6.Hollowell J.G., Staehling N.W., Flanders W.D., et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) J Clin Endocrinol Metab. 2002;87:489–499. doi: 10.1210/jcem.87.2.8182. [DOI] [PubMed] [Google Scholar]
- 7.Garancini M.P., Calori G., Ruotolo G., et al. Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study. Diabetologia. 1995;38:306–313. doi: 10.1007/BF00400635. [DOI] [PubMed] [Google Scholar]
- 8.Landis J.R., Koch G.G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977;33:363–374. doi: 10.2307/2529786. [DOI] [PubMed] [Google Scholar]
- 9.Byrt T. How good is that agreement? Epidemiology. 1996;7:561. doi: 10.1097/00001648-199609000-00030. [DOI] [PubMed] [Google Scholar]
- 10.Vitti P., Delange F., Pinchera A., et al. Europe is iodine deficient. Lancet. 2003;361:1226. doi: 10.1016/S0140-6736(03)12935-2. [DOI] [PubMed] [Google Scholar]
- 11.Vanderpump M.P., Tunbridge W.M., French J.M., et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 1995;43:55–68. doi: 10.1111/j.1365-2265.1995.tb01894.x. [DOI] [PubMed] [Google Scholar]
- 12.O’Leary P.C., Feddema P.H., Michelangeli V.P., et al. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol. 2006;64:97–104. doi: 10.1111/j.1365-2265.2005.02424.x. [DOI] [PubMed] [Google Scholar]
- 13.Bjoro T., Holmen J., Kruger O., et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. Eur J Endocrinol. 2000;143:639–647. doi: 10.1530/eje.0.1430639. [DOI] [PubMed] [Google Scholar]
- 14.Hoogendoorn E.H., Hermus A.R., de Vegt F., et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem. 2006;52:104–111. doi: 10.1373/clinchem.2005.055194. [DOI] [PubMed] [Google Scholar]
- 15.Bülow Pedersen I., Laurberg P., Knudsen N., et al. A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure. Clin Endocrinol. 2005;62:713–720. doi: 10.1111/j.1365-2265.2005.02284.x. [DOI] [PubMed] [Google Scholar]